GR3035287T3 - Insulin and amylin containing composition for the treatment of insulin deficient mammals. - Google Patents

Insulin and amylin containing composition for the treatment of insulin deficient mammals.

Info

Publication number
GR3035287T3
GR3035287T3 GR20010400101T GR20010400101T GR3035287T3 GR 3035287 T3 GR3035287 T3 GR 3035287T3 GR 20010400101 T GR20010400101 T GR 20010400101T GR 20010400101 T GR20010400101 T GR 20010400101T GR 3035287 T3 GR3035287 T3 GR 3035287T3
Authority
GR
Greece
Prior art keywords
insulin
amylin
treatment
containing composition
deficient mammals
Prior art date
Application number
GR20010400101T
Other languages
English (en)
Inventor
Timothy J Rink
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of GR3035287T3 publication Critical patent/GR3035287T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20010400101T 1991-05-24 2001-01-24 Insulin and amylin containing composition for the treatment of insulin deficient mammals. GR3035287T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
PCT/US1992/004351 WO1992020366A1 (en) 1991-05-24 1992-05-23 Insulin and amylin containing composition for the treatment of insulin deficient mammals

Publications (1)

Publication Number Publication Date
GR3035287T3 true GR3035287T3 (en) 2001-04-30

Family

ID=24831674

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400101T GR3035287T3 (en) 1991-05-24 2001-01-24 Insulin and amylin containing composition for the treatment of insulin deficient mammals.

Country Status (11)

Country Link
EP (1) EP0586592B1 (el)
JP (1) JPH06510753A (el)
AT (1) ATE197764T1 (el)
AU (2) AU2169392A (el)
CA (1) CA2109604A1 (el)
DE (1) DE69231583T2 (el)
DK (1) DK0586592T3 (el)
ES (1) ES2153828T3 (el)
GR (1) GR3035287T3 (el)
SG (1) SG44838A1 (el)
WO (1) WO1992020366A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656590A (en) * 1991-05-24 1997-08-12 Amylin Pharmaceuticals, Inc. Treatment of anorexia and related states
WO2001000223A2 (en) * 1999-06-25 2001-01-04 Minimed Inc. Multiple agent diabetes therapy
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment

Also Published As

Publication number Publication date
DK0586592T3 (da) 2000-12-27
JPH06510753A (ja) 1994-12-01
AU6196496A (en) 1996-10-10
DE69231583T2 (de) 2001-03-29
ES2153828T3 (es) 2001-03-16
CA2109604A1 (en) 1992-11-26
DE69231583D1 (de) 2001-01-04
WO1992020366A1 (en) 1992-11-26
EP0586592A1 (en) 1994-03-16
AU2169392A (en) 1992-12-30
SG44838A1 (en) 1997-12-19
EP0586592B1 (en) 2000-11-29
ATE197764T1 (de) 2000-12-15

Similar Documents

Publication Publication Date Title
ES2017471B3 (es) Aposito para el tratamiento de heridas y procedimiento de preparacion.
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
KR960014776B1 (en) Composition for stimulating hair growth
ZA858105B (en) A pharmaceutical composition and a method of treating the body
LTIP1582A (en) Compositions of medicinal preparation and hyaluronic acid for treatment of conditions and disease
IN166787B (el)
GB9517443D0 (en) Increasing creatine and glycogen concentration in muscle
HK16492A (en) Pharmaceutical compositions of somatostatin analogues
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
GR3031129T3 (en) Enhancement of glutathione levels with glutamine
BG104135A (en) Diabetes treatment with thiazolydindion, a form increasing the insulin and biguanide secretion
EP1952819A3 (en) Method for preventing gastritis using amylin or amylin agonists
GR860900B (en) Amino-propanol derivatives method for their preparation their use and medicaments containing them
GR3025792T3 (en) Use of phosphonates for the treatment of osteoporosis.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
IL103383A0 (en) Pharmaceutical compositions containing glutamine and methods for the use thereof
NO885023D0 (no) FremgangsmŸte for reduksjon av nitrogenoxydinnholdet i en avlsstr under anvendelse av sukker.
SG44838A1 (en) Insulin and amylin containing composition for the treatment of insulin deficient mammals
IL86928A (en) Castanospermine esters and glycosides,their preparation and compositions containing them for treating diabetes and postprandial hyperglycemia
EP0285441A3 (en) Synergistic immunostimulating composition and method
ZA871654B (en) Method and compositions for increasing mammary parenchyma
GR3022074T3 (en) Method for treatment or prevention of obesity.
PT85950A (en) Process for the preparation of protamine zinc insulin compositions useful for treating diabetes
CA2010054A1 (en) Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
GR1002317B (el) Προαγωγη της αναπτυξεως χοιρων.